Skip to main content
. 2021 Dec 4;11(12):1344. doi: 10.3390/life11121344

Figure 2.

Figure 2

The 5-year survival of patients with diagnosis of lung cancer after HTX stratified by stage according to UICC 8 (Kaplan–Meier estimator). Patients in stage I and II lung cancer after HTX had a significantly better 1-year (100.0% versus 3.6%), 2-year (69.2% versus 0.0%), and 5-year survival (53.8% versus 0.0%) than patients in stage III and IV lung cancer after HTX (p < 0.01). Abbreviations: HTX = heart transplantation; UICC 8 = 8th edition of the Union for International Cancer Control. * = statistically significant (p < 0.05).